Template:Hypertrophic cardiomyopathy: Difference between revisions

	Hypertrophic Cardiomyopathy Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Hypertrophic Cardiomyopathy from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X Ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Interventions
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Hypertrophic cardiomyopathy On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Hypertrophic cardiomyopathy
CDC on Hypertrophic cardiomyopathy
Hypertrophic cardiomyopathy in the news
Blogs on Hypertrophic cardiomyopathy
Directions to Hospitals Treating Hypertrophic cardiomyopathy
Risk calculators and risk factors for Hypertrophic cardiomyopathy

VisualWikitext

@@ Line 28: / Line 28: @@
 |- bgcolor="Pink"
 !
-[[Hypertrophic cardiomyopathy historical percpective|Historical Perspective]]
+[[Hypertrophic cardiomyopathy historical perspective|Historical Perspective]]
 |-
 !
@@ Line 160: / Line 160: @@
 |- bgcolor="PaleTurquoise"
 !
-Medical Therapy
+[[Hypertrophic cardiomyopathy medical therapy|Medical Therapy]]
-:[[Hypertrophic cardiomyopathy treatment strategy|Treatment Strategy]]
-:[[Hypertrophic cardiomyopathy medical treatment#Simple Supportive Measures|Supportive Therapy]]
-:[[Hypertrophic cardiomyopathy medical treatment#Pharmacotherapy|Pharmacotherapy]]
-:[[Hypertrophic cardiomyopathy medical treatment#2011 ACCF/AHA Guideline Recommendations: Pharmacologic Management in Symptomatic Patients|Guidelines]]
-|-
-!
-|- bgcolor="PaleTurquoise"
-!
-Medical Therapy
 |-
 !
@@ Line 207: / Line 197: @@
 !
 [[Hypertrophic cardiomyopathy Future or investigational therapies|Future or Investigational Therapies]]
-|-
-!
-|- bgcolor="PaleTurquoise"
-!
-Invasive Therapy
-:[[Hypertrophic cardiomyopathy alcohol septal ablation|Alcohol Septal Ablation]]
-:[[Hypertrophic cardiomyopathy septal myectomy|Septal Myectomy]]
-:[[Hypertrophic cardiomyopathy ventricular pacing|Ventricular Pacing]]
-:[[Hypertrophic cardiomyopathy automatic implantable cardiac defibrillator placement|Automatic Implantable Cardiac Defibrillator (AICD) Placement]]
-:[[Hypertrophic cardiomyopathy invasive therapy guidelines|Guidelines]]
-|-
-!
-|- bgcolor="PaleTurquoise"
-!
-[[Hypertrophic cardiomyopathy surgery#Cardiac transplantation|Cardiac transplantation]]
-|-
-!
-|- bgcolor="PaleTurquoise"
-!
-Special Scenario
-:[[Hypertrophic cardiomyopathy in special clinical scenarios#2011 ACCF/AHA Guideline Recommendations: Asymptomatic Patients (DO NOT EDIT)|Asymptomatic Patients]]
-:[[Hypertrophic cardiomyopathy management during childhood|Management During Childhood]]
-:[[Hypertrophic cardiomyopathy activities and circumstances to avoid|Activities/Circumstances to Avoid]]
-:[[Hypertrophic cardiomyopathy management during pregnancy|Management During Pregnancy]]
 |-
 !

Template:Hypertrophic cardiomyopathy: Difference between revisions

Latest revision as of 15:23, 10 March 2020

Navigation menu